121 related articles for article (PubMed ID: 37591406)
21. Molecular mechanisms of hepatic steatosis and insulin resistance in the AGPAT2-deficient mouse model of congenital generalized lipodystrophy.
Cortés VA; Curtis DE; Sukumaran S; Shao X; Parameswara V; Rashid S; Smith AR; Ren J; Esser V; Hammer RE; Agarwal AK; Horton JD; Garg A
Cell Metab; 2009 Feb; 9(2):165-76. PubMed ID: 19187773
[TBL] [Abstract][Full Text] [Related]
22. Adipsin deficiency does not impact atherosclerosis development in
Liu L; Chan M; Yu L; Wang W; Qiang L
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E87-E92. PubMed ID: 33135458
[TBL] [Abstract][Full Text] [Related]
23. Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
Lu Z; Li Y; Li AJ; Syn WK; Wank SA; Lopes-Virella MF; Huang Y
PLoS One; 2022; 17(11):e0277251. PubMed ID: 36331958
[TBL] [Abstract][Full Text] [Related]
24. Heat shock factor-1 knockout enhances cholesterol 7α-hydroxylase (CYP7A1) and multidrug transporter (MDR1) gene expressions to attenuate atherosclerosis.
Krishnamurthy K; Glaser S; Alpini GD; Cardounel AJ; Liu Z; Ilangovan G
Cardiovasc Res; 2016 Jul; 111(1):74-83. PubMed ID: 27131506
[TBL] [Abstract][Full Text] [Related]
25. An accelerated mouse model for atherosclerosis and adipose tissue inflammation.
Neuhofer A; Wernly B; Leitner L; Sarabi A; Sommer NG; Staffler G; Zeyda M; Stulnig TM
Cardiovasc Diabetol; 2014 Jan; 13():23. PubMed ID: 24438079
[TBL] [Abstract][Full Text] [Related]
26. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human Pathology.
van den Hoek AM; Verschuren L; Worms N; van Nieuwkoop A; de Ruiter C; Attema J; Menke AL; Caspers MPM; Radhakrishnan S; Salic K; Kleemann R
Cells; 2020 Sep; 9(9):. PubMed ID: 32883049
[TBL] [Abstract][Full Text] [Related]
27. Nuclear factor E2-related factor 2 deficiency impairs atherosclerotic lesion development but promotes features of plaque instability in hypercholesterolaemic mice.
Ruotsalainen AK; Lappalainen JP; Heiskanen E; Merentie M; Sihvola V; Näpänkangas J; Lottonen-Raikaslehto L; Kansanen E; Adinolfi S; Kaarniranta K; Ylä-Herttuala S; Jauhiainen M; Pirinen E; Levonen AL
Cardiovasc Res; 2019 Jan; 115(1):243-254. PubMed ID: 29917052
[TBL] [Abstract][Full Text] [Related]
28. Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-/-) gene lipodystrophic mice.
Agarwal AK; Sukumaran S; Cortés VA; Tunison K; Mizrachi D; Sankella S; Gerard RD; Horton JD; Garg A
J Biol Chem; 2011 Oct; 286(43):37676-91. PubMed ID: 21873652
[TBL] [Abstract][Full Text] [Related]
29. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
[TBL] [Abstract][Full Text] [Related]
30. Metabonomic Changes Associated with Atherosclerosis Progression for LDLR(-/-) Mice.
Li D; Zhang L; Dong F; Liu Y; Li N; Li H; Lei H; Hao F; Wang Y; Zhu Y; Tang H
J Proteome Res; 2015 May; 14(5):2237-54. PubMed ID: 25784267
[TBL] [Abstract][Full Text] [Related]
31. Pathology of congenital generalized lipodystrophy in Agpat2-/- mice.
Vogel P; Read R; Hansen G; Wingert J; Dacosta CM; Buhring LM; Shadoan M
Vet Pathol; 2011 May; 48(3):642-54. PubMed ID: 21051554
[TBL] [Abstract][Full Text] [Related]
32. Combined hyperlipidemia/hyperalphalipoproteinemia associated with premature spontaneous atherosclerosis in mice lacking hepatic lipase and low density lipoprotein receptor.
Barcat D; Amadio A; Palos-Pinto A; Daret D; Benlian P; Darmon M; Bérard AM
Atherosclerosis; 2006 Oct; 188(2):347-55. PubMed ID: 16384559
[TBL] [Abstract][Full Text] [Related]
33. A novel mouse model of diabetes, atherosclerosis and fatty liver disease using an AAV8-PCSK9-D377Y injection and dietary manipulation in db/db mice.
Xu M; Wu X; Liu Z; Ding Y; Kong W; Little PJ; Xu S; Weng J
Biochem Biophys Res Commun; 2022 Sep; 622():163-169. PubMed ID: 35868060
[TBL] [Abstract][Full Text] [Related]
34. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet.
Merat S; Casanada F; Sutphin M; Palinski W; Reaven PD
Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1223-30. PubMed ID: 10323773
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous severe hypercholesterolemia and atherosclerosis lesions in rabbits with deficiency of low-density lipoprotein receptor (LDLR) on exon 7.
Lu R; Yuan T; Wang Y; Zhang T; Yuan Y; Wu D; Zhou M; He Z; Lu Y; Chen Y; Fan J; Liang J; Cheng Y
EBioMedicine; 2018 Oct; 36():29-38. PubMed ID: 30243490
[TBL] [Abstract][Full Text] [Related]
36. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
[TBL] [Abstract][Full Text] [Related]
37. Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (
Burke AC; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Barrett PHR; Newton RS; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1178-1190. PubMed ID: 29449335
[TBL] [Abstract][Full Text] [Related]
38. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice.
Mulvihill EE; Assini JM; Sutherland BG; DiMattia AS; Khami M; Koppes JB; Sawyez CG; Whitman SC; Huff MW
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):742-8. PubMed ID: 20110573
[TBL] [Abstract][Full Text] [Related]
39. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in
Hoebinger C; Rajcic D; Silva B; Hendrikx T
Front Endocrinol (Lausanne); 2023; 14():1148827. PubMed ID: 37560305
[TBL] [Abstract][Full Text] [Related]
40. N-acetylcysteine attenuates atherosclerosis progression in aging LDL receptor deficient mice with preserved M2 macrophages and increased CD146.
Zhu Q; Xiao Y; Jiang M; Liu X; Cui Y; Hao H; Flaker GC; Liu Q; Zhou S; Liu Z
Atherosclerosis; 2022 Sep; 357():41-50. PubMed ID: 36041358
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
